申请人:ELI LILLY AND COMPANY LIMITED
公开号:EP0837061A1
公开(公告)日:1998-04-22
Pharmaceutical compounds of the formula
in which R1 is
Y or Y-C1-6 alkyl, where Y is carboxy, tetrazolyl, -SO2H, -SO3H, -OSO3H, -CONHOH, or -P(OH)OR', -PO(OH)OR'. -OP(OH)OR' or -OPO(OH)OR' where R' is hydrogen, C1-6 alkyl, C2-6 alkenyl or optionally substituted phenyl-C1-6 alkyl,
R2, R3 and R4 are each hydrogen, hydroxyl, halo, carboxy, C1-6 alkyl, carboxy-C1-6 alkyl, optionally substituted phenyl, optionally substituted phenyl-C1-6 alkyl or C2-6 alkenyl,
X and Z are each hydrogen, C1-6 alkyl, C3-7 cycloalkyl, optionally substituted phenyl, optionally substituted phenyl-C1-6 alkyl, optionally substituted naphthylmethyl, optionally substituted anthracenylmethyl,
where R'' and R''' are optionally substituted phenyl, or
where n is 0 or 1 to 3, Q is -O-, -NH-, -S-, -SO-, -SO2-, -CH2-, -CH=CH-, -CH2S-, -CH2O-, -CH2CH2- or -CONR'''' where R'''' is hydrogen or C1-6 alkyl, and R5, R6, R7, R8 and R9 are each hydrogen, halo, C1-6 alkyl, C1-6 alkyloxy or hydroxy;
provided that one of X and Z is hydrogen, or both of X and Z are hydrogen;
or a salt or ester thereof.
化合物的公式为其中R1是Y或Y-C1-6烷基,其中Y是羧基,四唑基,-SO2H,-SO3H,-OSO3H,-CONHOH,或-P(OH)OR',-PO(OH)OR',-OP(OH)OR'或-OPO(OH)OR',其中R'是氢,C1-6烷基,C2-6烯基或可选取代苯基-C1-6烷基,R2,R3和R4分别是氢,羟基,卤素,羧基,C1-6烷基,羧基-C1-6烷基,可选取代苯基,可选取代苯基-C1-6烷基或C2-6烯基,X和Z分别是氢,C1-6烷基,C3-7环烷基,可选取代苯基,可选取代苯基-C1-6烷基,可选取代萘基甲基,可选取代蒽基甲基,其中R''和R'''是可选取代苯基,或n为0或1至3,Q是-O-,-NH-,-S-,-SO-,-SO2-,-CH2-,-CH=CH-,-CH2S-,-CH2O-,-CH2CH2-或-CO NR''''其中R''''是氢或C1-6烷基,R5,R6,R7,R8和R9分别是氢,卤素,C1-6烷基,C1-6烷氧基或羟基;前提是X和Z中的一个是氢,或X和Z都是氢;或其盐或酯。